FLASCO | Association Partnerships

Latest from FLASCO

Roundtable Discussion: Perez Explores Therapeutic Options in RET-Mutated NSCLC

August 08, 2021

Molecular testing practices and treatment decisions can vary for patients with non–small cell lung cancer. Cesar A. Perez, MD, and a group of other physicians discussed next steps in care for a patient with non–small cell lung cancer whose molecular test results revealed a RET mutation.

Treatment Options Differ for Patients With Benign or Malignant Thyroid Cancer

October 29, 2019

Winston Tan, MD, discusses the current treatment landscape for patients with thyroid cancer. He highlighted the importance of first determining if a patient with thyroid cancer has benign or malignant thyroid nodules, which can be identified with the use of diagnostic biopsies. He also discussed the standard-of-care treatment options for these different subtypes of patients once they are identified.